HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mitchel S Berger Selected Research

Craniotomy

1/2022Reducing complication rates for repeat craniotomies in glioma patients: a single-surgeon experience and comparison with the literature.
4/2021Are preoperative chlorhexidine gluconate showers associated with a reduction in surgical site infection following craniotomy? A retrospective cohort analysis of 3126 surgical procedures.
1/2021Awake Craniotomy in Low-Resource Settings: Findings from a Retrospective Cohort in the Philippines.
5/2020Awake glioma surgery: technical evolution and nuances.
1/2020Awake craniotomy for resection of supratentorial glioblastoma: a systematic review and meta-analysis.
1/2020Disruption of Frontal Aslant Tract Is Not Associated with Long-Term Postoperative Language Deficits.
12/2019Supracerebellar Approach to Radiation-Induced Giant Capillary Telangiectasia Within Juvenile Pilocytic Astrocytoma of Upper Brainstem.
1/2018Cost-effectiveness development for the postoperative care of craniotomy patients: a safe transitions pathway in neurological surgery.
1/2018Intraoperative perception and estimates on extent of resection during awake glioma surgery: overcoming the learning curve.
12/2017Analysis of Cost Variation in Craniotomy for Tumor Using 2 National Databases.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mitchel S Berger Research Topics

Disease

132Neoplasms (Cancer)
01/2022 - 01/2002
84Glioma (Gliomas)
08/2022 - 01/2002
67Glioblastoma (Glioblastoma Multiforme)
10/2022 - 05/2002
44Brain Neoplasms (Brain Tumor)
01/2021 - 02/2002
12Astrocytoma (Pilocytic Astrocytoma)
08/2022 - 04/2003
11Meningioma (Meningiomas)
01/2022 - 10/2006
5Disease Progression
02/2021 - 09/2005
5Seizures (Absence Seizure)
10/2018 - 03/2011
5Necrosis
01/2017 - 06/2002
5Residual Neoplasm
07/2014 - 12/2003
4Oligodendroglioma
01/2022 - 12/2010
4Infections
06/2019 - 10/2002
4Carcinogenesis
12/2015 - 10/2002
3Edema (Dropsy)
01/2021 - 02/2005
3Neurocytoma
01/2020 - 12/2003
3Ependymoma
04/2014 - 07/2005
3Medulloblastoma
01/2013 - 07/2002
3Gliosarcoma
05/2010 - 11/2004
2Neurologic Manifestations (Neurological Manifestations)
01/2022 - 06/2019
2Cognitive Dysfunction
07/2021 - 01/2013
2Aneurysm (Aneurysms)
01/2021 - 07/2010
2Delirium
06/2019 - 01/2018
2Neoplasm Metastasis (Metastasis)
06/2017 - 01/2009
2Retinoblastoma (Glioblastoma, Retinal)
01/2014 - 01/2012
2Exanthema (Rash)
02/2009 - 12/2003
2Primitive Neuroectodermal Tumors (PNET)
12/2008 - 10/2005
1Leukocytosis (Pleocytosis)
01/2022
1Solitary Fibrous Tumors
01/2022

Drug/Important Bio-Agent (IBA)

26Temozolomide (Temodar)FDA LinkGeneric
11/2021 - 03/2003
16Proteins (Proteins, Gene)FDA Link
01/2022 - 07/2003
11AcidsIBA
05/2021 - 06/2013
11Pharmaceutical PreparationsIBA
12/2018 - 04/2004
10Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
04/2022 - 01/2012
9DNA (Deoxyribonucleic Acid)IBA
10/2021 - 03/2003
8Choline (Choline Chloride)IBA
08/2022 - 10/2002
7Biological ProductsIBA
01/2022 - 07/2003
7Messenger RNA (mRNA)IBA
02/2021 - 01/2009
6RNA (Ribonucleic Acid)IBA
01/2020 - 11/2003
6Liposomes (Liposome)IBA
01/2011 - 04/2004
5Anticonvulsants (Antiepileptic Drugs)IBA
01/2020 - 03/2011
5Phosphotransferases (Kinase)IBA
01/2020 - 05/2002
5ErbB Receptors (EGF Receptor)IBA
01/2019 - 06/2005
5Bevacizumab (Avastin)FDA Link
01/2016 - 06/2011
5LigandsIBA
10/2007 - 10/2004
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2007 - 10/2004
4Histones (Histone)IBA
01/2020 - 01/2011
4MethyltransferasesIBA
01/2020 - 03/2003
4MTOR InhibitorsIBA
11/2016 - 10/2005
4Heat-Shock Proteins (Heat-Shock Protein)IBA
06/2016 - 10/2007
4Irinotecan (Camptosar)FDA LinkGeneric
07/2014 - 03/2006
4Protons (Proton)IBA
01/2012 - 10/2002
4thiamine triphosphorate (TTP)IBA
07/2006 - 01/2004
3alpha-hydroxyglutarateIBA
08/2022 - 01/2012
3SteroidsIBA
01/2022 - 04/2004
3Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2020
3VaccinesIBA
01/2022 - 01/2013
3GadoliniumIBA
06/2021 - 08/2010
3Indicators and Reagents (Reagents)IBA
05/2021 - 08/2010
3protoporphyrin IXIBA
01/2021 - 05/2019
3LuciferasesIBA
11/2016 - 09/2007
3MicroRNAs (MicroRNA)IBA
06/2015 - 01/2011
3O(6)-Methylguanine-DNA MethyltransferaseIBA
09/2014 - 01/2004
3A-factor (Streptomyces)IBA
01/2011 - 12/2004
3Erlotinib Hydrochloride (CP 358,774)FDA Link
02/2009 - 06/2005
3Alkylating AgentsIBA
08/2007 - 12/2004
3N-acetylaspartate (N-acetyl aspartate)IBA
04/2007 - 10/2002
2Heme (Haem)IBA
02/2021 - 07/2020
2Doxorubicin (Adriamycin)FDA LinkGeneric
12/2018 - 06/2006
2Iodine-125IBA
06/2017 - 01/2009
2Mitogen-Activated Protein KinasesIBA
11/2016 - 11/2003
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
11/2016 - 11/2016
2Peptides (Polypeptides)IBA
01/2014 - 01/2013
2PTEN Phosphohydrolase (PTEN Phosphatase)IBA
03/2010 - 05/2002
2CreatineIBA
12/2009 - 05/2006
2epidermal growth factor receptor VIIIIBA
02/2009 - 06/2005
2Carmustine (FIVB)FDA Link
08/2008 - 11/2004
2CASP8 and FADD-Like Apoptosis Regulating Protein (FLIP-S)IBA
10/2007 - 10/2005
2Small Interfering RNA (siRNA)IBA
10/2007 - 11/2003
2IL13-PE38IBA
03/2007 - 04/2006
2Integrin alphaVbeta3IBA
12/2006 - 04/2004
2ExotoxinsIBA
04/2006 - 10/2003
2Coloring Agents (Dyes)IBA
11/2005 - 02/2002
2Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
06/2005 - 05/2002
2O(6)-benzylguanineIBA
01/2004 - 03/2003
1Inositol (Myoinositol)IBA
08/2022
1Phospho-Specific AntibodiesIBA
01/2022
1Cytostatic AgentsIBA
01/2022
1P-2 (P 2)IBA
01/2022
1poly ICLCIBA
01/2022
1Neurofibromin 2 (Merlin)IBA
01/2022

Therapy/Procedure

49Therapeutics
10/2022 - 06/2003
31Craniotomy
01/2022 - 05/2002
26Radiotherapy
11/2021 - 06/2003
19Drug Therapy (Chemotherapy)
04/2022 - 12/2003
6Length of Stay
04/2021 - 06/2002
5Immunotherapy
01/2022 - 01/2013
4Brachytherapy
06/2017 - 04/2004
3Operative Surgical Procedures
09/2019 - 04/2006
2General Anesthesia
09/2020 - 10/2015
2Adjuvant Radiotherapy
01/2016 - 02/2013